Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
It plays a crucial role in many of your body's functions
consistent ~12-15% weight loss at 68 weeks Compound Tirzepatide (Zepbound) Class GIP/GLP-1 dual agonist FDA Status FDA-approved for chronic weight management Evidence Strength Phase 3 RCTs
(USA) are currently the only two companies with GLP-1 medications approved for chronic weight management in the U.S
Fleming, S
Results of a randomized, double-blind, placebo-controlled clinical study
US$ 28.51
US$ 20.97
US$ 25.78
US$ 23.19
US$ 26.70
US$ 25.61
